Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery

Overview

Individuals operated for rhegmatogenous retinal detachment will be prospectively evaluated for postoperative retinal shift. Fundus autofluorescence will be used to evaluate retinal shift that will be correlated to visual acuity, metamorphopsia, aniseikonia, and stereopsis.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2020

Clinical Trial Outcome Measures

Primary Measures

  • Retinal shift
    • Time Frame: 2 years
    • Measured on fundus autofluorescence

Secondary Measures

  • Visual acuity
    • Time Frame: 6 and 24 months
    • Best Corrected Visual Acuity
  • Metamorphopsia
    • Time Frame: 6 and 24 months
    • M-Chart
  • Aniseikonia
    • Time Frame: 6 and 24 months
    • New Aniseikonia Test
  • Stereopsis
    • Time Frame: 6 and 24 months
    • Titmus Test

Participating in This Clinical Trial

Inclusion Criteria

  • Acute rhegmatogenous retinal detachment, fovea detached, able to signe Exclusion Criteria:

  • Secondary retinal detachment like tractional, serous or with ora serrata dialysis, fovea on

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Helse Stavanger HF
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Vegard Forsaa, MD, Study Director, Helse Stavanger HF

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.